Skip to content

Does Avacopan Make You Tired? Understanding Fatigue as a Side Effect of Tavneos

4 min read

According to the Phase 3 ADVOCATE trial, approximately 10% of patients taking avacopan reported fatigue as an adverse event. This means that while some individuals may experience increased tiredness while on the medication, it is not an issue for everyone. It's important for patients to consider that their underlying condition, ANCA-associated vasculitis, is a known cause of debilitating fatigue, which complicates identifying the specific source of tiredness.

Quick Summary

Avacopan (Tavneos) can cause fatigue, but its role in managing ANCA-associated vasculitis can lead to a reduced reliance on steroids, which may ultimately improve a patient's overall energy levels. It is crucial to monitor for signs of serious complications like liver issues or infection, which can also manifest as severe or worsening fatigue.

Key Points

  • Fatigue is a Reported Side Effect: In clinical trials, around 10% of patients experienced fatigue while taking avacopan (Tavneos).

  • Fatigue is a Symptom of the Underlying Disease: ANCA-associated vasculitis itself often causes severe fatigue, which can be difficult to distinguish from a medication side effect.

  • Avacopan Can Reduce Steroid Side Effects: By reducing the need for high-dose steroids like prednisone, avacopan can indirectly improve patient fatigue and overall quality of life.

  • Warning Sign for Serious Complications: Worsening tiredness can be a symptom of a serious liver problem or an infection and should be reported to a doctor immediately.

  • Lifestyle Management Can Help: Strategies such as prioritizing rest, maintaining a regular routine, and managing stress can help patients cope with fatigue.

  • Individual Response Varies: The experience of fatigue is unique to each patient and can be influenced by multiple factors, including disease severity and other co-existing health issues.

In This Article

Is Fatigue a Common Side Effect of Avacopan?

Yes, fatigue is a potential and relatively common side effect of avacopan (brand name Tavneos). In the ADVOCATE clinical trial, which studied avacopan for the treatment of ANCA-associated vasculitis, fatigue was reported by about 10.2% of patients receiving avacopan, compared to 9.1% of patients in the prednisone control group. While the incidence was only slightly higher with avacopan in this study, the overall context for patients with this autoimmune condition is complex.

Patients with ANCA-associated vasculitis frequently experience severe and persistent fatigue, which profoundly affects their quality of life, even when the disease is in remission. Therefore, any new or worsening fatigue while on avacopan requires a careful evaluation by a healthcare provider to determine whether it is a drug side effect, a symptom of the underlying disease, or a sign of a more serious issue.

Potential Causes of Fatigue on Avacopan

While the drug itself can cause fatigue, the symptom can also be a red flag for more serious complications. These include:

  • Liver Problems: Avacopan can cause serious liver injury. Warning signs of liver issues include unusual or worsening fatigue, yellowing of the skin or eyes (jaundice), abdominal pain, or dark urine. Patients on avacopan are monitored with regular blood tests to check liver function.
  • Infections: As an immunosuppressant, avacopan increases the risk of serious infections. Fatigue can be a flu-like symptom of an infection, along with fever, cough, and body aches.
  • Underlying Disease: The fatigue associated with ANCA-associated vasculitis can be relentless and may not resolve completely, even with effective treatment.

Avacopan vs. Prednisone: Impact on Fatigue and Quality of Life

For many patients with ANCA-associated vasculitis, avacopan serves as a complementary treatment that allows for a significant reduction in glucocorticoid (steroid) usage, such as prednisone. This is a crucial distinction, as chronic steroid use is associated with its own set of severe side effects that can negatively impact a patient's quality of life. The ability to minimize or avoid high-dose steroids is a major benefit of avacopan therapy.

Comparing Key Side Effects: Avacopan vs. Prednisone

Side Effect Avacopan (Tavneos) Prednisone (Standard of Care)
Fatigue Reported in clinical trials, but also addresses the disease-related fatigue. Underlying disease plus steroid-induced effects contribute to fatigue.
Cardiovascular Risks Hypertension is a known side effect. High blood pressure, weight gain, and increased risk of cardiovascular events are common concerns with long-term steroid use.
Metabolic Changes Some studies show favorable metabolic outcomes compared to prednisone. Can cause steroid-induced diabetes, weight gain, and changes in glucose tolerance.
Musculoskeletal Issues Muscle spasms and arthralgia can occur. Associated with muscle spasms and potential bone density loss with long-term use.
Infection Risk Increased risk of serious infections, such as pneumonia and UTIs. Also increases risk of serious infections.

How Avacopan Might Actually Help with Fatigue

Interestingly, some research suggests that by effectively controlling the inflammatory process of ANCA-associated vasculitis, avacopan could potentially improve a patient's overall fatigue levels. This happens because the inflammatory process itself is a major contributor to the profound tiredness seen in this patient population. By inhibiting the complement 5a (C5a) receptor, avacopan helps calm the overactive immune response. For some patients, this control of inflammation, combined with the reduction of high-dose steroid side effects, results in clinically meaningful improvements in health-related quality of life, including better energy levels.

Tips for Managing Fatigue While on Avacopan

If you are experiencing fatigue while taking avacopan, you can take several steps to help manage the symptom:

  • Prioritize Rest: Allow yourself to rest without guilt. Napping can help your body recover.
  • Maintain a Routine: Stick to a regular daily schedule, including consistent bedtimes and wake-up times, to help regulate your body's energy.
  • Practice Good Sleep Hygiene: Avoid caffeine and electronics later in the day. Create a relaxing bedtime routine, such as taking a warm bath or reading.
  • Manage Stress: Use meditation, spend time with loved ones, or engage in hobbies to help renew mental energy and cope with stress.

When to Contact Your Doctor

It's important to differentiate typical fatigue from symptoms of a serious issue. You should contact your healthcare provider immediately if your tiredness is accompanied by any of the following:

  • Yellowing of the skin or eyes
  • Abdominal pain or dark urine
  • Fever, chills, or persistent cough
  • Signs of an allergic reaction, such as swelling of the face or lips

Conclusion

While avacopan (Tavneos) does list fatigue as a possible side effect, its impact on tiredness is complex. For many patients with ANCA-associated vasculitis, a condition inherently linked to debilitating fatigue, avacopan's ability to reduce or eliminate high-dose steroid use may lead to an overall improvement in quality of life and energy levels. However, it's crucial for patients to be aware that severe or unusual fatigue could signal a more serious underlying issue, such as liver damage or infection. Open communication with your doctor and proactive management of fatigue are key to a successful treatment plan.

Comparison of Avacopan's Impact on Quality of Life

The ADVOCATE study showed that patients taking avacopan experienced statistically significant improvements in health-related quality of life measures compared to those on prednisone, particularly concerning physical function and general health perceptions. This evidence supports the therapeutic value of avacopan in managing not just the disease activity but also its broader impact on patient well-being.

Frequently Asked Questions

No, fatigue is not a guaranteed side effect. While some patients in clinical trials reported fatigue, only about 10% experienced it. The experience can vary greatly from person to person.

For some patients, yes. By controlling the underlying inflammation associated with ANCA-associated vasculitis and reducing the need for high-dose steroids, avacopan may lead to an overall improvement in quality of life, including a reduction in disease-related fatigue.

In the ADVOCATE trial, fatigue was reported at similar rates in both avacopan and prednisone groups. However, avacopan avoids many of the significant, often fatigue-inducing, side effects associated with long-term high-dose steroid use, which can lead to a net positive effect on energy for many patients.

You should contact your healthcare provider immediately. Worsening fatigue can be a symptom of a serious complication, such as liver injury or an infection, which needs immediate medical attention.

Yes. Practicing good sleep hygiene, maintaining a consistent daily schedule, prioritizing rest, and managing stress through activities like meditation can help manage fatigue.

Yes, it is possible. Fatigue can be a lingering symptom of the underlying ANCA-associated vasculitis itself, or it could be a sign of another health issue, such as an infection. Your doctor can help determine the cause.

No, avacopan is not classified as a sedative. It is a complement 5a receptor (C5aR) antagonist used to treat ANCA-associated vasculitis. Fatigue and dizziness are potential side effects, but it is not intended to cause drowsiness.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.